 reuters    u s  senator chuck grassley asked the department of defense and the department of veterans affairs on tuesday to explain spending trends for the epipen emergency allergy treatment  the request followed a recent report by reuters detailing how epipen price hikes by manufacturer mylan nv had added millions to u s  department of defense spending since  as the agency covered more prescriptions for the lifesaving allergy shot at near retail prices   we know the price increase for epipens is hitting individual consumers and medicare and medicaid   grassley  a republican  said in a statement    we need to determine whether taxpayers overpaid for the epipen through the department of defense and the va and whether they deserve a rebate  as they do with medicaid   spending that isn t warranted squeezes the health care budget   mylan agreed last month to pay   million to settle questions of whether it underpaid u s  government healthcare programs by misclassifying epipen   the company raised the price for a package of two epipens by sixfold to more than   over the last decade  